2018 annual financial data
Summit Therapeutics 2018 Net margin
Direct answer
Net margin was 19.04%.
Operating income was 5,389,000 GBP and net income was 10,869,000 GBP.
Operating cash flow was -35,106,000 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 57,088,000 GBP
- Operating income
- 5,389,000 GBP
- Net income
- 10,869,000 GBP
- Operating cash flow
- -35,106,000 GBP